Bruce A Donzanti

Senior Group Director | Global Pharmacovigilance Innovation Policy | USA

Genentech Inc., A Member of the Roche Group


Bruce has a PhD in pharmacology/neuroscience with almost 30 years of experience in the pharma/biotech industry.  After serving in the US Army, he entered academics where he performed research on mechanisms of neuronal degeneration and neurotoxicology and lectured in neuropharmacology to graduate and medical students.  He continued his pre-clinical research in industry before moving into clinical development and eventually Medical Affairs. Bruce has held various positions in industry, including Head of Drug Safety at Genentech and now Senior Group Director of Pharmacovigilance Innovation Policy in Global Regulatory Affairs.  In this role, Bruce works with key stakeholders to focus on new methodologies in pharmacovigilance as well as its current challenges.